Topical antifungal treatment cures exit-site fungal infection.

Abstract

Exit-site fungal infection, although rarely reported, may be a critical complication in patients on peritoneal dialysis. There is no optimal treatment of exit-site fungal infection. We report four cases of exit-site infection with Candida parapsilosis. Four-week treatment with topical sulconazole cream was administered. Fungal infection was cured in all patients but followed by exit-site bacterial infection in two patients. The topical application of sulconazole cream is recommended for exit-site fungal infection.

• Authors: Wen-Ding Hsu, Shuei-Liong Lin, Felin-Lin Wu, Chih-Kang Chiang, Kwan-Dun Wu
• Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation (Am J Kidney Dis) Vol. 40 Issue 4 Pg. E15 (Oct 2002) ISSN: 1523-6838 [Electronic] United States
• PMID: 12324936 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright 2002 by the National Kidney Foundation, Inc.

Chemical References

• Antifungal Agents
• Imidazoles
• sulconazole

Topics

• Administration, Topical
• Adult
• Aged
• Antifungal Agents (administration & dosage, therapeutic use)
• Candida (drug effects, isolation & purification)
• Candidiasis (complications, diagnosis, drug therapy)
• Catheters, Indwelling (adverse effects, microbiology)
• Female
• Humans
• Imidazoles (administration & dosage, therapeutic use)
• Peritoneal Dialysis, Continuous Ambulatory (adverse effects)